Theravance Biopharma Inc. (TBPH)
NASDAQ: TBPH
· Real-Time Price · USD
13.14
0.20 (1.55%)
At close: Aug 15, 2025, 3:59 PM
13.16
0.15%
After-hours: Aug 15, 2025, 06:33 PM EDT
Theravance Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -58.33M | -56.42M | -49.4M | -45.65M | -44.77M | -55.19M | -60.94M | -96.42M | -88.97M | -92.82M | -110.6M | -101.48M | -145.69M | -199.43M | -225.83M | -264.16M | -274.64M |
Depreciation & Amortization | 3.49M | 3.62M | 4.34M | 4.51M | 4.46M | 4.26M | 4.86M | 5.24M | 6.52M | 7.02M | 7.39M | 8.68M | 8.9M | 9.71M | 9.8M | 9.17M | 9.01M |
Stock-Based Compensation | 21.04M | 21.39M | 21.39M | 22.69M | 23.58M | 25.37M | 26.5M | 28.77M | 32.21M | 39.73M | 49.7M | 55.54M | 60.77M | 62.06M | 60.69M | 61.89M | 63.53M |
Other Working Capital | 18.13M | 20.57M | 8.02M | 3.98M | -3.31M | -7.66M | 56.19M | 41.98M | 45.67M | 46.68M | -22.12M | -9.09M | -9.81M | -11.46M | -16.03M | -20.45M | -23.96M |
Other Non-Cash Items | 7.07M | 12.04M | 13.18M | 11.76M | 8.7M | 3.7M | -176.57M | -149.45M | -168.59M | -183.28M | -4.97M | -28.65M | -10.29M | 3.86M | -6.31M | -14.75M | -22.68M |
Deferred Income Tax | -8.91M | -7.57M | 899K | 810K | 2.69M | 3.21M | 1.32M | 1.32M | n/a | n/a | -22.16M | -47.46M | -49.23M | -44.48M | -22.31M | 2.99M | 4.75M |
Change in Working Capital | 68.17M | 20.36M | 3.05M | 2.05M | -6.51M | -8.34M | 54.63M | 40.7M | 46.69M | 42.35M | -24.72M | -15.32M | -28.53M | -39.58M | -46.4M | -57.07M | -45.13M |
Operating Cash Flow | 32.53M | -11.54M | -11.49M | -8.78M | -16.8M | -27M | -150.2M | -169.85M | -172.14M | -186.99M | -105.37M | -128.68M | -164.06M | -207.86M | -230.35M | -261.93M | -265.17M |
Capital Expenditures | -241K | -332K | -819K | -825K | -1.64M | -2.49M | -2.08M | -2.06M | -1.32M | -629K | -807K | -1.85M | -1.89M | -3.41M | -4.21M | -5.22M | -7.43M |
Cash Acquisitions | n/a | n/a | -1.51M | -1.51M | -210K | n/a | -1.1B | -1.09B | -1.09B | -1.09B | 4.58M | 1.87M | 1.85M | 6K | 6K | n/a | n/a |
Purchase of Investments | -118.1M | -143.03M | -103.02M | -58.14M | -26.9M | -134.53M | -144.42M | -183.92M | -219.5M | -103.14M | -146.79M | -172.05M | -176.44M | -158.31M | -169.21M | -161.51M | -337.25M |
Sales Maturities Of Investments | 144.23M | 155.65M | 99.76M | 72.26M | 54.62M | 102.81M | 152.12M | 169.13M | 201.73M | 158.02M | 173.5M | 186.5M | 219.2M | 286.2M | 339.41M | 435.03M | 400.63M |
Other Investing Acitivies | n/a | 17.12M | 18.63M | 18.63M | 30.53M | -28.7M | 1.07B | 2.16B | 2.16B | 2.2B | 1.12B | 20.75M | 49.05M | 162.66M | 151.42M | 151.45M | 115.53M |
Investing Cash Flow | 25.89M | 12.28M | -4.08M | 13.3M | 27.38M | -32.7M | 7.14M | 1.08B | 1.08B | 1.15B | 1.13B | 14.47M | 42.72M | 124.49M | 166.04M | 268.37M | 56.02M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -631.6M | -631.6M | -631.6M | -631.6M | n/a | -5.03M | -10.73M | -10.73M | -10.73M | -5.7M |
Common Stock Repurchased | -2.26M | -3.1M | -33.36M | -64.36M | -145.03M | -199.55M | -204.56M | -267.85M | -187.07M | -132.28M | -96.95M | -4.54M | -4.92M | -9.06M | -9.42M | -8.12M | -8.54M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -386.73M | -386.73M | -386.73M |
Other Financial Acitivies | 508K | 508K | 548K | 547K | 618K | 618K | 759K | 5.04M | 5.08M | 5.08M | 5.37M | 1.09M | 3.47M | 3.47M | 4.42M | 4.45M | 4.6M |
Financial Cash Flow | -1.64M | -2.5M | -32.74M | -63.77M | -144.41M | -198.93M | -203.8M | -894.42M | -813.6M | -758.81M | -723.18M | -3.44M | 101.7M | 91.86M | 92.45M | 93.78M | -9.63M |
Net Cash Flow | 56.78M | -1.75M | -48.31M | -59.25M | -133.83M | -258.63M | -346.85M | 18.3M | 93.3M | 208.21M | 297.12M | -117.65M | -19.64M | 8.5M | 28.14M | 100.21M | -218.79M |
Free Cash Flow | 32.28M | -11.87M | -12.31M | -9.6M | -18.44M | -29.48M | -152.28M | -171.85M | -173.4M | -187.56M | -106.12M | -130.53M | -165.95M | -211.26M | -234.56M | -267.15M | -272.6M |